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KELANTAN AND MATERNAL 
HEALTH CARE 
1 KELANTAN AND MATERNAL HEALTH CARE 
1.1 INTRODUCTION 
1.1.1 Background 
Kelantan is one of thirteen states in Malaysia, and located in the northeastern comer 
of Peninsular Malaysia. Kelantan was blessed in a flash of lightning. According to 
popular belief, the name of Kelantan was derived from "kilatan", the Malay word for 
lightning, a cosmic phenomenon frequently lighting the way for early seafarers sailing 
into the mouth of the Kelantan River. 
The Land of Lightning, an intriguing potpourri of multi-cultural, multi-religious 
influences that gives it what the locals call the Kelate' flavour. The Kelate' dialect in 
itself is interesting as many words in the dialect are not found in the Malay language. 
Kelantan is by far the most unique state in Peninsular Malaysia. It is often referred to 
as the "Cradle of the Malay Culture" as the culture and age-old traditions are still very 
much alive till this day. Here, colourful kites or well known as 'wau bulan' soar 
upwards defying gravity and giant drums reverberate. Shadow puppets or 'wayang 
kulit' mesmerise audiences and giant tops provide hours of endless fun. Dubbed as 
"The Home of the Cottage Industries", traditional crafts such as Batik, Songket, Silver 
craft, Wood Carving, Kris Making are some of the many types of Cottage Industries 
you will find here as you journey through the Land of Lightning. 
It has an area of 14,931 square kilometres. Rustic settings of picturesque villages and 
amidst padi-fields give insights into a way of life that endured the passing of time. It 
is also the most fascinating part of Peninsular Malaysia encompassing picturesque 
beaches, padi fields, rubber estates, palm oil plantations and fishing villages. 
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Kelantan has a population of about 1.4 million; 95% is Malay with Chinese, Indians, 
Thais and Orang Asli making up the rest. Kelantanese are renowned for their warmth 
and friendliness. Kelantan Darul Nairn is a world of gracious beauty, retaining old-
world charm that few can resist. 
1.1.2 History 
Kelantan's earliest known history dates back to the Middle Stone Age between 3,000 
and 8,000 B.C.Chinese historical chronicles speaks of existence of city-states or 
kingdoms in the east coast of the Malay Peninsula which maintained contacts with the 
Chinese court. Kelantan was subsequently referred to as 'Ho-lo-tan', 'Chih-Tu' and 
'Tan-Tan' in these records. According to a Chinese record it was said that in 1225, 
Kelantan was part of the Srivijaya Empire, while an old Javanese poem 
'Nagarakretagama' tells us that in 1345, Kelantan was a dependency of the kingdom 
of Majapahit. 
When Islam came to Malay world, Kelantan became one of the earliest Muslim states 
in the region. At the turn of the 19th century, following a brief war between Kelantan 
and Terengganu, the eldest son of Late Long Yunus named Long Muhammad 
managed to drive the Terengganu forces out ofKelantan and became Sultan 
Muhammad I in 1800. His descendants presently make up the Royal house of 
Kelantan. Kelantan came under Thai and British influence before becoming part of 
the Federation ofMalaya in 1957 and Malaysia in 1963. 
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1.1.3 Economy 
Kota Bharu (KB) is the administrative capital and major urban centre of Malaysia's 
northern Kelantan province. There are plans to open the southern portion of the state 
under an ambitious multi-million dollar development. 
Kelantan's industry is heavily based on agriculture. Palm Oil plantations abound here, 
as do large and small rubber estates. Rice (padi) is grown in great quantities here as 
are vegetables. One only needs to visit the Central Market in Kota Bharu to begin to 
get a sense of how important agriculture is in the Kelantan peoples' lives. Padi (or rice 
growing) is the major economic activity in Kelantan. Utilising both traditional and 
modem methods, Kelantan has many hectares devoted to padi growing. Kelantan 
annual rice output: 200,000 metric tonnes (14% of Malaysia's total output). 
Tobacco is a major cash crop in Kelantan. Many fields can be seen just outside of 
Tum pat and are also being grown in many of the coastal areas. 
Rubber plantations occupy the countryside in Kelantan, whether large estates or small 
plots of trees. Rubber workers can be seen working the trees, collecting the raw 
rubber latex and drying rubber mats in the sun, and preparing for processing. Kelantan 
rubber-based annual output: 60,000 metric tonnes. 
With 100 kilometres of coastline, Kelantan supports a fishing industry that is known 
throughout Peninsular Malaysia. Scenic fishing villages such as Kampung Sabak also 
draw tourists from all over the world. Kelantan fisheries industry contributes over 25 
%of Malaysia's output wholesale value of marine fish exceeding RM 1.79 billion. 
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Palm oil covers about 70,000 hectares in Kelantan. Products of Palm oil include 
' 
vegetable ghee, margarine, glycerine, fatty acids, palm kernel oil and cake, amongst 
others. Malaysia is also planning to manufacture cars that run on palm oil. Kelantan 
palm oil annual output: 138,000 metric tonnes (crude oil). 
Coconut trees are widely found throughout Kelantan especially in coastal areas. 
There are at present 18,000 hectares of land under cultivation. Products of coconuts 
include coconut 'milk', juice, oil, copra and coconut candy. 
In addition to the primary role of agriculture and its related businesses, there is a 
continuous contribution from the Kelantan cottage industries. Most are based on 
handicraft items such as batik, silver craft, basket weaving and songket weaving, that 
cannot be overlooked. 
As Malaysia has become recognised worldwide as an upcoming economic power, 
with economic growth far in advance of most of the world; Kelantan's own economic 
growth has been nothing short of phenomenal. This can be attributed to proper 
planning and commitment in both the public and private sectors. Key economic areas 
have been identified and expanded with proper planning and supervision. The high 
growth rate can in part be attributed to the diversification of the Kelantan economy 
and it continues to point toward an above average growth rate. 
Agriculture is the mainstay ofKelantan's economy with approximately 32% of the 
Gross Domestic Product. Rubber and Padi (rice) are the main crops. Tobacco is fast 
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developing as an important cash crop as well. Other important crops are coconut, 
cocoa, com and vegetables. 
Forestry in the past, has played and important part in the economy. Remote areas of 
Kelantan have been opened for development. With the growing concern over the 
harvest of tropical hardwoods, logging is on a decline. This has created a paradoxical 
problem, in that the price of various tropical hardwoods has steadily risen making it 
more and more profitable to harvest this timber, benefiting the state and economy as 
well as those businesses that harvest the timber. 
Tourism is rapidly developing as an established part of the Kelantan economy as more 
people throughout the world become aware of the unique opportunities Kelantan 
offers. For travel, variety, culture, and excellent value per dollar spent, Kelantan 
offers what few areas anywhere can; a wonderful experience at a reasonable price. 
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1.2 MATERNALHEALTHCARE 
The events pertinent to maternal health care started in Kelantan in 1930, when the 
first General Hospital was built. Training programs for midwives was initiated and 
this was upgraded in1946. In 1956, the National Rural Health Development program 
started with an extensive development of health infrastructures in the form of Rural 
Health Units organized on a 3 tiers and now 2-tier system of referral for Maternal and 
Child Health care. 
The various maternal health care services provided included antenatal care, postnatal 
care and family planning. Over the years, the state medical and health services have 
improved tremendously with the opening of district hospitals and health centers. 
There are altogether nine hospitals in the state - 2 in Kota Bharu and one each in each 
of districts except Bachok and Jeli. Previously, specialist services were provided only 
at Kota Bharu Hospital and Hospital Universiti Sains Malaysia. Obstetric operations 
are only carried out at these two tertiary care hospitals. Recently starting from 1998, 
Kuala Krai Hospital was upgraded and at present Obstetrician and Gynaecologist, 
Anaesthesiologist and Pathologist are giving their specialist services to improve 
health status at that area. 
The improvement was also reflected the increasing numbers of hospitals deliveries. 
The hospital delivery was only 12.7% of all deliveries in1980 and 15.0% in 1987. In 
1992 there were tremendous improvement, with 60.1% delivered in hospital and this 
' 
was also accompanied by reduction in maternal mortality rate and perinatal mortality 
rate. 
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1.2.1 MATERNALMORTALITYRATE 
The Maternal Mortality Rate (Ml\.1R) in Kelantan has declined from 1.1 per 1,000 live 
births in 1980 to 0.55 per 1,000 live births in 1986. Since then, the rate has dropped 
further to 0.46 per 1,000 live births in 1995 (Figure 1.1) 
Figure 1.1 Maternal Mortality Rate in Kelantan, 1980 - 1995 
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There were 24 maternal deaths in 1993, 19 in 1994 and 18 in 1995. The districts with 
relatively high maternal mortality rates were Kuala Krai district, Pasir Mas district 
and Machang district. The rate were also high in Pasir Puteh district and Gua Musang 
district in 1993 but in 1995 the rates in both districts had dropped to zero (Table 1.1) 
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Table 1.1 Numbers of Maternal Deaths and Maternal Mortality Rate in 
Kelantan by Districts, 1993-1995 
District No. Of Maternal Deaths Maternal Mortality Rate* 
1993 1994 1995 1993 1994 1995 
KotaBharu 7 5 3 0.54 0.40 0.23 
Tum pat 1 0 2 0.26 0.00 0.57 
Bachok 1 2 2 0.26 0.55 0.56 
PasirPuteh 4 1 0 1.09 0.28 0.00 
PasirMas 2 4 4 0.39 0.82 0.91 
Mac hang 2 3 2 0.76 1.16 0.80 
KualaKrai 3 2 4 0.94 0.63 1.37 
Tanah Merah & Jeli 2 1 1 0.41 0.21 0.3 
GuaMusang 2 1 0 1.07 0.55 0.00 
Total 24 19 18 0.57 0.47 0.46 
*Per 1,000 live births 
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Table 1.2 Maternal Mortality Rate In 1980, 1985, 1990 and 1994 by State 
State Maternal Mortality Rate (per 1,000 Live births) 
1980 1985 1990 1994 
Perl is 60.0 79.9 41.8 19.6 
Kedah 80.0 54.6 25.6 20.3 
Penang 40.0 30.7 16.5 27.3 
Perak 70.0 44.7 22.4 28.5 
Selangor 30.0 13.8 19.5 13.0 
Kuala Lumpur 10.0 12.5 3.3 21.5 
Negeri 50.0 40.8 10.6 10.9 
Sembilan 
Malacca 40.0 6.4 21.0 6.7 
Job ore 150.0 24.0 26.9 26.8 
Pahang 110.0 59.5 31.6 30.4 
Terengganu 70.0 57.4 15.2 11.4 
Kelantan 50.0 60.6 16.6 16.2 
Sa bah 10.0 20.2 19.3 15.4 
Sarawak 60.0 10.0 6.7 14.5 
Malaysia 10.0 37.1 20.2 19.1 
Source: Department of Statistics, Malaysia. 
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1.2.2 PERINATAL MORTALITY RATE 
The perinatal mortality rate per 1,000 live births in Kelantan has dropped from 22.76 
in 1985 to 12.92 in 1994. In comparison to the state average, district ofGua Musang, 
Kuala Krai, Tanah Merah, Jeli, Pasir Mas and Tumpat had higher perinatal mortality 
rate in 1994 (Table 1.4) 
Table 1.3 Perinatal Mortality Rate In 1985, 1990 and 1994 by State 
State Perinatal Mortality Rate 
(per 1,000 Live births and Stillbirths) 
1985 1990 
Perl is 24.9 13.9 
Kedah 24.5 17.7 
Penang 18.6 15.0 
Perak 21.5 12.6 
Selangor 12.9 11.1 
Kuala Lumpur 8.7 10.4 
Negeri Sembilan 19.2 15.2 
Malacca 20.3 16.2 
Johore 20.1 12.4 
Pahang 21.2 20.4 
Terengganu 23.6 16.0 
Kelantan 22.7 12.4 
Sabah 15.0 14.0 
Labuan N.A N.A 
Sarawak 8.4 8.2 
Malaysia 18.0 13.4 
*including Federal Temtory ofLabuan 1n 1985 and 1990 
N.A =Not Available 
Source: Department of Statistic, Malaysia. 
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1994 
7.4 
15.8 
13.8 
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11.4 
Table 1.4 Perinatal Mortality Rate in Kelantan, 1985, 1990 and 1994 
District 1985 1990 1994 
KotaBharu 20.78 12.12 8.11 
Bachok 18.53 9.12 10.55 
Tum pat 25.02 13.45 14.06 
PasirMas 25.11 13.32 17.64 
Mac hang 17.03 12.33 10.00 
PasirPuteh 19.31 10.68 12.10 
KualaKrai 26.52 11.83 17.93 
GuaMusang 27.21 17.62 18.00 
Jeli * * 17.00 
TanahMerah 29.40 13.58 19.29 
Kelantan 22.76 12.45 12.92 
Source: Vital Statistics ofMalaysia, 1985, 1990 and 1994 
* Jeli and Tanah Merah was single district until1994. 
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THE SCHOOL OF MEDICAL 
SCIENCES 
UNIVERSITI SAINS MALAYSIA 
2 THE SCHOOL OF MEDICAL SCIENCES- UNIVERSITI SAINS 
MALAYSIA 
The school of Medical Sciences, Universiti Sains Malaysia is one of the medical 
schools in Malaysia and was set up in mid 1979. The uniqueness of this school lies in 
the fact that it is the first medical school in the country to adopt an innovative, 
community-orientated curriculum for its medical students. 
Its philosophy is to stress the relevance of its curriculum to the needs of the country 
and the profession and to work towards producing competent practitioners who would 
be able to identify themselves as part and parcel of health care system of the country. 
It is the first medical school to be set up in the less developed eastern coast of West 
Malaysia, the other medical school being located in Kuala Lumpur, the capital city i.e. 
University of Malaya and National University of Malaysia. 
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2.1 HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM) 
Hospital University Science Malaysia (HUSM) is the teaching hospital for the School 
of Medical Sciences, University Science Malaysia. It was built in 1976 under the 
Third Malaysia Plan and is located at Kubang Kerian town about 6.4 km from the 
state capital Kota Bharu. The construction was completed in 1984 and was officially 
opened by the Royal Highness Al-Sultan Kelantan on 26th August 1984. The first 
patient was admitted on 21 51 January 1984 and frrst baby was born in Aprill984. 
Besides teaching and research, the University Hospital also provides adequate 
medical services for the population. It also serves as the referral center for the state 
and the neighbouring states in the East Coast. 
The hospital has a total of 675 beds for medical and surgical disciplines. All the 
departments are adequately staffed and the hospital has backup services by the blood 
bank, laboratory and radiological units. 
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2.2 THE DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY (HUSM) 
In 2001, the department of Obstetrics and Gynaecology is staffed by eleven 
consultants/lecturers, nine registrars (the final year master students), thirty medical 
officers and I or trainee lecturers (five third year masters, ten second year masters and 
two first year masters) and twelve house officers. The postgraduate program was 
started in 1991 and the first Master of Medicines candidates in Obstetrics and 
Gynaecology graduated in June 1995. 
The department of Obstetrics and Gynaecology occupies the first floor of the new 
hospital building above the Obstetrics and Gynaecology clinic. There is one 
gynaecology ward in the first floor of the hospital main building, with total of 31 beds, 
and two obstetric wards in the second floor of the new hospital building with a total of 
80 beds (40 beds antenatal and 40 beds postnatal). 
The Labour ward is situated on the first floor of the new hospital building, adjacent to 
neonatal intensive care unit. It is equipped with ten one-bedded delivery rooms, two-
bedded admission room, two-bedded eclampsia or intensive care room and one-
bedded premature room. There are no special induction rooms, patient were induced 
either in the obstetric wards or in labour room (if high risk). The labour ward is 
equipped with two ultrasound machines, five tococardiography (CTG) machines, 
dynamaps, ECG monitors, infusion pumps, two resuscitation trolleys and blood 
warmer. 
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There is an operation theatre in the labour ward, which is opened during the office 
hours for providing epidural services and anaesthesia for emergency and elective 
operative procedures. 
The Special Care Nursery is housed next to labour room and is equipped with 
facilities for the care of the problem newborns. The total deliveries, mode of 
deliveries, perinatal and maternal mortality rate for Hospital Universiti Sains 
Malaysia since 1990 ti112000 were as in Table 2.1. 
Table 2.1 Basic Statistics for Department of Obstetrics and Gynaecology, 
Hospital Universiti Sains Malaysia, 1990 - 2000 
Year 1990 1991 1992 1993 1.994 1995 19% 1997 19'AJ 1999 2(8) 
Taal 5996 6874 8184 8844 9478 8ID4 7(f9 7712 6930 7778 74!67 
crJivaies 
~of 
crJivaies 
(D/o) 
SVD 74.8 743 78.7 793 79.8 ~.1 793 793 81.1 82.6 82.7 
Vacuum 3.0 33 22 22 29 29 3.4 2.9 22 24 12 
...... 32 26 26 20 23 12 15 1.0 1.1 1.0 1.1 I'UIUllS 
I.BCS 13.4 152 11.8 123 10.5 113 10.7 124 13.6 11.8 11.6 
Breech 4.0 3.1 3.4 3.0 24 27 28 26 21 20 24 
Twins 1.6 1.5 13 12 1.1 1.0 1.0 1.0 09 12 1.0 
Still 2h2 20.0 182 16.8 14.6 133 14.5 13.0 152 11.6 10.6 
Birth* 
PMR* 332 2h.6 15.7 20.7 18.8 19.1 23.1 21.9 23.9 
~ 33.4 727 61.0 67.8 10.5 352 522 13.0 
*Per 1000 
#Per 100,000 
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The Obstetrics and Gynaecology clinic is situated at the ground floor of the new 
hospital building and it is equipped with two ultrasound machines and a colposcope 
machine. The clinics run as follows in Table 2.2. 
Table 2.2 Obstetrics and Gynaecology Clinic Schedule in HUSM 
DAY MORNING AFTERNOON 
Saturday (second and Booking Antenatal Clinic Booking Antenatal Clinic 
fourth week) 
Sunday Antenatal Outpatient Clinic Gynaecology Outpatient 
Clinic 
Monday Menopause Clinic Molar and Oncology 
Outpatient Ultrasound Clinic 
Tuesday Antenatal Outpatient Clinic Gynaecology Outpatient 
Clinic 
Wednesday Fertility Augmentation Family Planning and 
Clinic Postnatal clinic 
The number of outpatient seen from 1990 till 2000 were as shown in Table 2.3 
Table 2.3 The number of Outpatients Seen from 1990 till 2000 
YEAR GYNAECOLOGY OBSTETRICS 
OUTPATIENT OUTPATIENT 
1990 3439 10049 
1991 3587 11881 
1992 3763 12279 
1993 4315 12674 
1994 4331 12321 
1995 4174 10296 
1996 4725 10146 
1997 5319 11741 
1998 5664 11826 
1999 6026 9854 
2000 5945 9144 
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hospital building and it is equipped with two ultrasound machines and a colposcope 
machine. The clinics run as follows in Table 2.2. 
Table 2.2 Obstetrics and Gynaecology Clinic Schedule in HUSM 
DAY MORNING AFTERNOON 
Saturday (second and Booking Antenatal Clinic Booking Antenatal Clinic 
fourth week) 
Sunday Antenatal Outpatient Clinic Gynaecology Outpatient 
Clinic 
Monday Menopause Clinic Molar and Oncology 
Outpatient Ultrasound Clinic 
Tuesday Antenatal Outpatient Clinic Gynaecology Outpatient 
Clinic 
Wednesday Fertility Augmentation Family Planning and 
Clinic Postnatal clinic 
The number of outpatient seen from 1990 till 2000 were as shown in Table 2.3 
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3 ABSTRACT OF DISSERTATION 
3.1 BAHASA MALAYSIA VERSION 
Objektif: 
Mengkaji glukos plasma berpuasa (fasting plasma glucose) sebagai ujian 
penyaringan bagi penyakit kencing manis ketika mengandung (gestational diabetes 
mellitus). Objektif selanjutnya adalah untuk menentukan taburan demografi bagi 
penyakit kencing manis ketika mengandung dan menilai pecahan penyakit ini yang 
dapat dikesan melalui saringan selektif menggunakan faktor sejarak 
Metodologi: 
Kajian bersilang telah dijalankan di Hospital Universiti Sains Malaysia (HUSM), 
Kubang Kerian, Kelantan dari bulan Julai 1999 hingga bulan Oktober 2000. Data 
asas diambil daripada 461 pesakit yang bersetuju mengambil bahagian di dalam 
kajian ini, yang mana umur kandungannya tidak melebihi 28 minggu dan tidak 
mempunyai penyakit kencing manis sebelum ini. Ujian glukos piawai 2-jam 75-g telah 
dijalankan ke atas 370 pesakit. Penyakit kencing manis semasa mengandung dan 
subkategorinya iaitu kencing manis dan gangguan toleransi terhadap glukos semasa 
mengandung telah didefinasikan oleh mengikut 'Definition, Diagnosis and 
Classification of Diabetes Mellitus and its Complications. Part 1 :Diagnosis and 
Classification of Diabetes Mellitus Provisional Report of a WHO Consultation'. Ciri-
ciri saringan glukos plasma berpuasa dikaji melalui kiraan sensitiviti dan spesifisiti 
dengan 'receiver operator characteristic curves'. 
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Keputusan: 
Melalui kajian ini didapati plasma glukos berpuasa ~7. 0 mmo/11 mempunyai 
sensitiviti (17.8%) yang amat rendah dalam mengesan kencing manis semasa 
mengandung secara keseluruhan. Sensitiviti (62.5%) meningkat sekiranya ia 
digunakan bagi mengesan subkategori kencing manis semasa mengandung. Walau 
bagaimanapun, plasma glukos berpuasa ~7. 0 mmolll adalah amat spesifik {> 98%) 
dalam mengesan kedua-dua keadaan ini. Gangguan glukos berpuasa (Impaired 
Fasting Glucose) didapati mempunyai sensitiviti sebanyak 1.8% sahaja dan spesifisiti 
sebanyak 97.1% dalam mengesan subcategori gangguan toleransi glukos semasa 
mengandung (gestational impaired glucose tolerance). 
Mengikut kajian ini, plasma glukos berpuasa melebihi atau bersamaan 4.4 mmolll 
berkebolehan mencapai sensitiviti sebanyak 75.3% dan spesifisiti sebanyak 66.3% 
dalam mengesan kencing manis semasa mengandung secara keseluruhan. Sekiranya 
4.3 mmo/1/ diambil sebagai had atas bagi normal dan 7.0 mmo/11 atau lebih sebagai 
penyakit kencing manis semasa mengandung, ujian glukos ke atas 61.9% pesakit 
dapat dikurangkan. Dengan menggunakan cara ini, 19 atau 5.1% pesakit termasuk ke 
dalam klasifikasi yang salah dengan 18 atau 4.9% daripadanya adalah keputusan 
negatif palsu (false negative). 
Umur yang meningkat didapati mempunyai kaitan dengan peningkatan kejadian 
penyakit kencing manis semasa mengandung. Walaupun pecahan pesakit yang 
mempunyai pariti yang banyak ada/ah tinggi (25.1%), ia tidak berkaitan dengan 
peningkatan kejadian kencing manis semasa mengandung. Kebanyakan pesakit yang 
disahkan menghidapi kencing manis semasa mengandung adalah Melayu kerana 
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kebanyakan pesakit yang menyertai kajian ini ada/ah Melayu. Walaupun terdapat 
sedikit peningkatan di da/am kejadian penyakit kencing manis semasa mengandung 
dengan meningkatnya nilai indeks jisim badan (Body Mass Index), ia didapati tidak 
signifikan. Tiada terdapat perbezaan dalam kejadian penyakit kencing manis semasa 
mengandung yang signifikan jika dibandingkan antara pesakit daripada kumpulan 
pendapatan yang berbeza. 
Didapati 45.3% pesakit normal mempunyai satu at au lebih faktor risiko untuk 
mendapat kencing manis semasa mengandungjika faktor sejarah digunakan sebagai 
saringan. Jni bermakna hampir separuh pesakit yang normal atau 36.4% daripada 
semua pesakit terpaksa menjalani ujian g/ukos sedangkan ia mungkin tidak 
diperlukan. Selain daripada itu, didapati 30.1% daripada pesakit yang menghidap 
kencing man is semasa mengandung tidak dapat dikesan melalui saringan secara ini. 
Kesimpulan: 
Me/aui kajian ini didapati plasma glukos berpuasa yang dahulunya telah diabaikan 
sebagai a/at saringan bagi mengesan penyakit kencing manis semasa mengandung 
ada/ah berpotensi kerana mudah, murah, praktikal dan mesra pengguna. 
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3.2 ENGLISH VERSION 
Objective: 
To evaluate fasting plasma glucose as a screening test for gestational diabetes mellitus. 
Further objectives were to determine demographic distribution of gestational diabetes 
mellitus and to assess the proportions of gestational diabetes mellitus picked up by 
selective screening using historical risk factors alone. 
Methods: 
A hospital-based, cross-sectional study was carried out at University Hospital, 
Universiti Sains Malaysia (HUSM), Kubang Kerian, Kelantan, from July 1999 till 
October 2000. Baseline data from 461 women who agreed to participate in the study 
with gestational ages less than 28 weeks and no previous diagnosis of diabetes were 
collected. A standardized 2-h 75-g oral glucose tolerance test was performed in 370 
women. Gestational diabetes and its subcategories-diabetes and gestational impaired 
glucose tolerance-were defined according to the Definition, Diagnosis and 
Classification of Diabetes Mellitus and its Complications. Part 1 :Diagnosis and 
Classification of Diabetes Mellitus Provisional Report of a WHO Consultation. 
Screening properties of fasting plasma glucose were evaluated by calculating 
sensitivity and specificity with receiver operator characteristic curves. 
Results: 
In this study, fasting plasma glucose level of~7.0 mmoVl has a very low sensitivity 
(17.8%) in detecting gestational diabetes mellitus as a whole. The sensitivity (62.5%) 
improves if the cut-off level is used to detect subcategory gestational diabetes mellitus. 
However, fasting plasma glucose level of~7.0 mmoVl is highly specific (>98o/o) in 
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detecting both conditions. Impaired fasting glucose or IFG was found to have 
sensitivity of only 1. 8% and specificity of 97.1% in detecting subcategory gestational 
impaired glucose tolerance. 
Based on this study, fasting plasma glucose of 4.4 mmol/1 or more is able to reach a 
sensitivity of75.3% and a specificity of66.3% in detection ofGDM as a whole. 
Taking 4.3 mmol/1 as the upper limit of normal and 7.0 mmol/1 or more as confirmed 
gestational diabetes mellitus, oral glucose testing in 61.9% of patients could be 
eliminated. By using this strategy, 19 or 5.1% were misclassified with 18 or 4.9% 
being false negative. 
Advancing age was significantly associated with increase incidence of GDM. 
Although the proportions of patients who were grandmultiparous and great 
grandmultiparous (25 .1%) were high, it was not shown to be significantly associated 
with GDM. Majority of those diagnosed as GDM were Malay as majority of patients 
in this study were Malay. Although slight increase in incidence of GDM were shown 
with increase BMI in this study but it was not statistically significant. There was also 
no significant difference in incidence of GDM among various income groups. 
Using historical factors as a screening, 45.3% of normal patients were noted to have 
one or more risk factor for developing GDM, which means that nearly half of normal 
or 36.4% of all patients would undergo unnecessary oral glucose testing. Furthermore, 
30.1% ofGDM without a risk factor would be totally missed out. 
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Conclusions: 
While previously neglected as a screening test for GDM, in our population the FPG 
offers a potentially simple, practical algorithm to screen for GDM by being cost-
effective and patient friendly. 
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4 INTRODUCTION AND THEORETICAL ASPECTS OF 
FASTING PLASMA GLUCOSE AS A SCREENING TEST FOR 
GESTATIONAL DIABETES MELLITUS (GDM) 
4.1 INTRODUCTION 
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance 
with onset or first recognition during pregnancy. The definition applies regardless of 
whether insulin or only diet modification is used for treatment or of whether the 
condition persist after pregnancy. It does not exclude the possibility that unrecognized 
glucose intolerance may have antedated or begun concomitantly with the pregnancy 
(1). Six weeks or more after pregnancy ends, the woman should be reclassified, into 
one of the following categories (2): 
• Diabetes mellitus (DM) 
• Impaired fasting glucose (IFG) 
• Impaired glucose tolerance (IGT) 
• Normoglycaemia 
In the majority of cases of GDM, glucose regulation will return to normal after delivery. 
Women who become pregnant and who are known to have diabetes mellitus which 
antedates pregnancy do not have gestational diabetes but have 'diabetes mellitus and 
pregnancy' and should be treated accordingly before, during and after the pregnancy 
(2). 
4.2 PREVALENCE 
GDM complicates 4% of all pregnancy in United States (3). The prevalence may range 
from 1 to 14% of pregnancies, depending on population studied (3). The prevalence of 
GDM is highly dependent on ethnicity and geographical variations ( 4 ). Compared with 
the white European women, the prevalence rate for GDM is increased approximately 
eightfold in South East Asian women (5). Using the O'Sullivan screening with 50-g 
glucose followed by 75-g 2-h oral glucose tolerance test (OGTT) as the diagnostic tool, 
the prevalence of gestational diabetes in Malaysia was 12.7% with 10.2% in the 
Malays, 19.5% in the Indians and 17.5% in the Chinese (6). 
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4.3 SCREENING METHODS: WHO TO TEST 
Clinical recognition of GDM is important because therapy including diet, insulin when 
necessary, and antepartum fetal surveillance, can reduce the well-described GDM-
associated perinatal morbidity and mortality (7). It is also related to maternal 
complications that include an increased rate of caesarean section and chronic 
hypertension (7-9). Although many patients diagnosed with GDM will not develop 
diabetes later in life, others will be diagnosed many years postpartum as having type 1 
diabetes, type 2 diabetes, IFG or IGT ( 1 0-15). 
The purpose of a screening test is not to diagnose a disease, but to identify a subgroup 
of a given population that is at risk for a given disorder. To maximize the utility of a 
screening test, it should be well defined, easily administered, inexpensive, reproducible, 
and it should optimize sensitivity, perhaps at the expense of some specificity. 
Previous recommendations have been that screening for GDM be performed in all 
pregnancy. However there are certain factors that place women at lower risk for 
development of glucose intolerance during pregnancy, and it is likely not cost effective 
to screen such patients. Thus, selective screening is currently widely accepted. 
Advancing maternal age was noted to be associated with increased incidence of GDM. 
Using National Diabetes Data Group (NDDG) criteria in a population based study of 
6,214 gravidae, Coustan et al. (16) found the incidence ofGDM to be 0.5% in women 
less than twenty years of age. It rose to 4. 0% in pregnant women in the age group of 
thirty-five to thirty-nine years. Based on this, proposals have been made that because 
the majority of cases of GDM occurs in women over the age of twenty-four years, 
screening for GDM should be limited to those gravidae more than twenty-four years 
old. Of pregnant women under the age of twenty-four years, only those with one or 
more of the historical or clinical risk factors mentioned previously would be included in 
the screened group. 
Other low risk group patients are women who are of normal body weight, have no 
family history (i.e., first degree relative) of diabetes, and are not members of an 
ethnic/racial group of high prevalence of diabetes (e.g. Hispanic, Native American, 
Asian, African-American) need not be screened for GDM ( 17 -19). Being Asian, this 
puts most of pregnant women in our population in a high-risk group. 
The other option is to narrow the population to be screened by taking the historical risk 
factors into account. From the very beginning, it was apparent that there were items that 
were more frequent in the histories or clinical presentations of women found to have 
GDM. Among these factors were reproductive events, including a prior neonate 
weighing more than 4.0 kg or a prior neonatal death, congenital anomaly, or 
prematurity, a family history of overt diabetes; and clinical findings during pregnancy 
that include obesity, excessive weight gain, glycosuria, proteinuria and hypertension. 
Several investigators have examined the efficiency of these historical risk factors at 
narrowing the group to be screened (Table 4.1; 16,17,20,21). Very consistently, these 
investigators have found these historical risk factors in only roughly half of the women 
known to have GDM. That means that if risk factors alone determined who was to be 
screened one half of GDM would not be detected. 
' 
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Table 4.1 Maternal historical and clinical risks factors in gestational diabetes 
mellitus 
Reference n (GDM/population) Percentage of GDM 
subjects with risk 
factors(%) 
O'Sullivan et al. (20) 15/752 53 
Lavin (21) 30/2,077 47 
Marquette et al. (17) 12/434 50 
Coustan et al. (16) 125/6,214 56 
Moses et al. (22) evaluated the effect of excluding lean young Caucasian women with 
no family history of diabetes and not coming from an ethnic/racial group with high 
prevalence of diabetes from screening and found that outcomes in low risk women 
were similar to those in high risk women. Women from low risk group have a 2.8% 
prevalence rate of GDM and nearly 10% of cases of GDM would be missed. 
A group from University of Michigan (23) has also done the same evaluation and found 
that although only 4% of women will be missed but approximately 90% of pregnant 
women will still need to be screened for GDM. 
4.4 SCREENING METHODS: HOW TO TEST 
Screening method using 50-g glucose challenge test as suggested by American 
Diabetes Association (ADA) is widely practiced and accepted in the U.S. Table 4.2 (24) 
presents the sensitivities and specificities associated with several thresholds in use. 
Table 4.2 Sensitivity and specificity of 50-g 1-h oral glucose challenge as a 
function of threshold value 
Threshold ( mmol/1) 
7.2 7.5 7.8 
Sensitivity (%) 100 98 79 
S_l!_ecificity (%) 78 80 87 
In 1989, Sacks et al. (25) perfonned 50-g glucose screens on two consecutive days on 
110 women, 30 with confinned GDM and 80 without GDM. Of 30 gravidae with 
confinned GDM, 3 had glucose screen values< 7.5 mmoVl on both days, and 10 more 
had values that straddled 7.5 mmoVI on successive days. Of 80 normal control subjects, 
11 had glucose screen values that straddled 7.5 mmoVl on successive days. Had they 
relied on a single normal test value, Sacks et al. would have missed 8 of the 30 cases of 
GDM on a given day. Relying on normal test values on both days would miss 3 of 30 
cases of GDM. Keeping in mind that reproducibility was one of the criteria for a good 
screening test, it was concluded that the 50-g 1-h glucose screen was moderately 
reliable, and caution was given not to rely on a single normal test result, particularly in 
someone with risk factors. 
Other than being troublesome and at times not palatable, the cost of screening our 
population for GDM with the 50-g glucose screen would be considerable. 
Test other than the 50-g oral glucose challenge that could be used to screen for GDM is 
the measurement of glycated proteins. This method allows the blood to drawn from an 
unprepped patient, which is more convenient. Glycation is a non-enzymatic process 
that is both time dependent and glucose-concentration dependent and occurs largely at 
the NH2-terminal amino acids or side-chain lysine groups. Being time and glucose-
concentration dependent, some potential problems may interfere with using glycated 
proteins as screening tests for GDM. 
These problems include the following: 
• Pregnant women have lower fasting blood glucose than non pregnant 
women 
• Pregnant women have higher postprandial blood glucose than non pregnant 
women 
• Because of increased erythropoeisis in pregnancy, the red blood cells of 
pregnant women are younger and their haemoglobin less glycated than those 
of non pregnant women 
• At the time of GDM screening, the interval of any potential carbohydrate 
intolerance would have been of relatively short duration 
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Table 4.3 presents sensitivity and specificity of various glycated proteins used in 
screening of GDM. 
Table 4.3 Sensitivity and specificity of glycated proteins in screening for GDM 
Reference Protein Sensitivity (o/o) Specificity (%) 
Roberts et al. (26) Albumin 85 95 
Nasrat et al. (27) Albumin 50 -
Shah et al. (28) Haemoglobin 22 90 
Artal et al. (29) Haemoglobin 73 34 
Cousins et al. (30) Haemoglobin 80 57 
Hughes et al. (31) Albumin 79 77 
Other alternatives to the 50-g oral glucose challenge are fasting plasma glucose (FPG), 
timed blood glucose (TBG), random blood glucose (RBG) and glycosuria (Table 4.4) 
Table 4.4 Alternatives to the 50-g oral glucose screen for GDM 
Method Reference Comments 
Fasting Sacks et al. For FPG 4.9 mmol/1, 
plasma (32) sensitivity = 80%; specificity = 40% 
glucose For FPG 4. 7 mmol/l, 
(FPG) sensitivity = 90%; specificity = 21% 
For FPG 4.5 mmolll, 
sensitivity = 95%; specificity = 11% 
Timed blood Nasrat et al. TBG >5.9 mmol/1 and> 2 h postprandial 
glucose (33) or 
(TBG) TBG >6.9 mmol/1 and< 2 h postprandial 
Sensitivity = 29%; specificity = 89% 
Random Stangenberg RBG >6.5 mmol/1 in 174 of 1,500 women 
blood glucose et al. (34) 10 had abnormal GTT; 
(RBG) GDM incidence of 0. 7% suggests substantial false 
negative 
Glycosuria Lind (35) Glycosuria found in 50% of all pregnancies 
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4.5 SCREENING METHODS: WHEN TO TEST 
Screening is customarily done between 24 and 28 weeks gestation. Recommendations 
that screening for GDM be done between 24 and 28 weeks are based on the physiology 
ofGDM: a gradual decrease in carbohydrate intolerance in the second trimester leads to 
increased blood glucose concentrations and increased postprandial insulin-to-glucose 
ratios. In 1985, Jovanovic and Peterson (36) performed 50-g glucose challenges on 300 
gravidae at 9-20 weeks. They repeated the challenge at 27-31 weeks on original 300 
minus those found to have abnormal glucose tolerance tests (GTT) after the first screen, 
plus an additional 300 women. Finally, they repeated the challenge on the whole group 
at 33-36 weeks. The interval of 27-31 weeks had the highest percentage of positive 
screens. That interval also had the highest percentage of abnormal GTT. Additionally; a 
positive screen between 27 and 31 weeks was associated with macrosomia more often 
than positive screen at the other times. These data provide strong support for the 
custom of screening in interval from week 24 to week 28 of pregnancy. 
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4.6 SCREENING METHODS: FASTING PLASMA GLUCOSE (FPG) 
The interest to evaluate fasting plasma glucose as a screening tool for GDM arise as a 
result of the current trend of utilizing FPG in diagnosis of diabetes in non pregnant 
subject. 
In 1997, an International Expert Committee, working under the sponsorship of the 
American Diabetes Association modified diagnostic criteria for diabetes mellitus in 
non-pregnant subjects as shown in Table 4.5. Three ways to diagnose diabetes are 
possible, and each must be confirmed, on subsequent day, by any one of the three 
methods given in Table 4.5 (2). 
Table 4.5 Criteria for diagnosis of diabetes mellitus in non pregnant individuals 
by ADA 
1. Symptoms of diabetes plus casual plasma glucose concentration ~ 11.1 mmoVl 
Casual is defined as any time of day without regard to time since last meal. 
The classic symptoms of diabetes include polyuria, polydypsia and unexplained 
weight loss. 
or 
2. FPG ~ 7.0 mmol/1 
Fasting is defined as no caloric intake for at least 8 hours. 
or 
3. 2hPG ~11.1 mmol/1 
The test should be performed as described by WHO (3 7), using glucose load 
containing the equivalent of 75g anhydrous glucose dissolved in water. 
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Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) refer to a 
metabolic stage intermediate between normal glucose homeostasis and diabetes. The 
Expert Committee recognizes this group of subject whose glucose levels, although not 
meeting criteria for diabetes, are nevertheless too high to be considered altogether 
nonnal. 
Thus, the categories ofFPG values are as follows: 
Normal fasting glucose FPG < 6.1 mmoVl 
Impaired fasting glucose FPG ~ 6.1 and< 7.0 mmoVl 
Provisional diagnosis of diabetes FPG ~ 7.0 mmoVl 
The corresponding categories when the OGTT is used are the following: 
Normal glucose tolerance 2-h post load glucose (2hPG) < 7.8 mmoVl 
Impaired glucose tolerance 2hPG ~ 7.8 and< 11.1 mmoVl 
Provisional diagnosis of 2hPG ~ 11.1 mmol/1 
diabetes 
The 
2
_h OGTT cutoff of 7. 8 mmol/1 will identify more people as having impaired 
I h tasl
·s than will the fasting cutoff of 6.1 mmol/1. Almost all individuals 
g ucose omeos 
with FPG ~7. 8 mmol/1 have 2hPG ~11.1 mmol/1 if given OGTT, where as only about 
one fourth of those with 2bPG ~11.1 mmolll and without previously known diabetes 
8 1/1(38) Thus the cut point ofFPG ~7.8 mmol/1 defined a greater have FPG ~7. mmo · ' 
I 
mia than did the cut point of 2hPG ~ 11.1 mmol/1. 
degree of hyperg ycae 
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The major change in the diagnostic criteria for diabetes mellitus from previous WHO 
recommendation is the lowering of the diagnostic value of the fasting plasma glucose 
concentration to 7.0 mmolll and above, from the former level of7.8 mmoVI and above. 
The new fasting criterion is chosen, as it approximately equal in diagnostic significance 
to 2-h post-load concentration. Furthermore, several studies have shown increased risk 
in microvascular and macrovascular disease in persons with fasting plasma glucose 
concentration of7.0 mmolll and over. 
In summary, the diagnostic criteria are now revised to 
• avoid the discrepancy between the FPG and 2hPG cut point values 
• facilitate and encourage the use of simpler and equally accurate test 
(FPG) for diagnosing diabetes 
• reproducibility is another important property of a diagnostic test, a 
property for which the FPG appears to preferable 
• when OGTTs were repeated during 2 - 6-week interval, the intra-
individual coefficients of variation were 6.4% for FPG and 16.7% for 
the 2hPG (39) 
However, for epidemiological studies, estimates of diabetes prevalence and incidence 
should be based on an FPG 7. 0 mmolll as OGTT may be difficult to perform, time 
consuming and not cost effective. 
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In the report of the Expert Committee of ADA and American College of Obstetricians 
and Gynaecologists (ACOG}, the two-step process - a 50-g screening test and, if that is 
positive, a 100-g diagnostic test (Table 4.6)- is the testing scheme recommended for 
the pregnant women as it is so widely accepted and practiced in the U.S (1). 
Table 4.6 Screening and diagnosis scheme for GDM 
Plasma glucose 50 g screening test 100 g diagnostic test 
(mmol/1) (mmol/1) 
Fasting - 5.8 
1-h 7.8 10.6 
2-h - 9.2 
3-h - 8.1 
There have been challenges to the above diagnostic scheme. Carpenter and Coustan ( 40) 
have suggested that the National Diabetes Data Group (NDDG) conversion of the 
O'Sullivan and Mahan values from the original Somogyi-Nelson determinations may 
have resulted in values that are too high. They proposed cut off values for plasma 
glucose that appear to represent more accurately the original O'Sullivan and Mahan 
determinations. In three studies, these criteria identified more patients with GDM 
whose infants had perinatal morbidity (41-43).1n addition, efforts are being made to 
established internationally agreed upon diagnostic testing procedures: for example, 
using the 75-g oral glucose load, as recommended by WHO, because that protocol 
identifies a greater number of pregnancies with maternal or perinatal complications 
associated with high plasma glucose ( 44-46). 
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In 1998, WHO Consultation has taken place in parallel with the report by the American 
Diabetes Association Expert Committee to re-examine its own diagnostic criteria. Since 
1980, the WHO panels recommends the use in pregnancy of the same diagnostic 
procedures used for non-pregnant adults: a 75-g oral load with fasting and a 2-h plasma 
glucose test (47-49). The revised criteria for diagnosis of diabetes in non pregnant 
subjects agreed by both ADA Expert Committee and WHO in 1998 are shown in Table 
4.7. 
Table 4.7 Values for diagnosis of diabetes mellitus and other categories of 
hyperglycaemia 
Glucose concentration (mmolll) 
Diabetes Mellitus: 
Fasting ~ 7.0 
or 
2-h post glucose load ~ 11.1 
or both 
Impaired Glucose Tolerance (IGT): 
<7.0 Fasting 
and 
2-h post glucose load ~ 7. 8 and < 11.1 
Impaired fasting glycaemia (IFG): 
Fasting ~ 6.1 and< 7.0 
As proposed by ADA Expert Committee, WHO has also changed its criteria by 
lowering of the diagnostic value of fasting plasma glucose concentration to 7.0 mmol/1 
from the former level of7.8 m.mol/1. The new fasting criterion is chosen to represent a 
value, which in most persons is of approximately equal diagnostic significance to that 
of 2-h post load concentration. 
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Following that, WHO classifies pregnant women who meet WHO criteria for diabetes 
mellitus or IGT as having GDM. The significance of IFG in pregnancy remains to be 
established. Any woman with IFG, however, is recommended to have a 75-g OGTT. 
In Europe, the 75-g, 2-h OGTT is popular as the diagnostic test for GDM without any 
screening procedure. However, there is less agreement on glucose values used for 
diagnosis with the WHO, the European Diabetic Pregnancy Study Group and Fourth 
International Workshop-Conference on GDM interpreting the results differently ( 49). 
In view of the current move towards using FPG as a diagnostic tool, it is also important 
to evaluate its usefulness as a screening test in detecting GDM. 
The fasting plasma glucose was compared with the one-hour post glucose test as a 
screening test for identification of gestational diabetes by Sacks et al. (32). Of 4,561 
consecutive patients screened with a 50-g glucose test, 968 {21.2%) had results~ 7.5 
mmoVI; 141 (14.6%, or 3.1% oftotal) were found to have diabetes. In the 968 patients, 
the area under the fasting plasma glucose receiver operating characteristic curve was 
greater than that under the glucose screening test curve, indicating greater 
discriminatory value of the former test. 
Furthermore, of the 116 patients who had sequential glucose screening tests and fasting 
plasma glucose performed twice during pregnancy, a significant correlation was found 
for fasting plasma glucose values, but not for glucose screening test values. 
l:S 
FPG appears to have a better reproducibility property and remains relatively stable 
throughout pregnancy (50). If compared with OGTTs that were repeated in adults 
during a two to six weeks interval, the intra-individual coefficients variation were 6.4% 
for FPG and 16.7% for the 2hPG (39) 
A group of researchers in Brazil (51) had performed a study to evaluate FPG as a 
screening test and found that for detection of subcategory gestational diabetes, a FPG of 
4.9 mmol/ljointly maximizes sensitivity (88%) and specificity (78%). For detection of 
subcategory gestational impaired glucose tolerance (GIGT), a value of 4. 7 mmol/1 
jointly maximizes sensitivity and specificity (68%). The performance ofFPG assessed 
against GDM as a whole is comparable to those reported by Sacks et al. (Table 4.8) 
Table 4.8 Selected sensitivities, corresponding specificities and screening test 
threshold values 
Reference FPG Sensitivity (%) Specificity (%) (mmol/1) 
Sacks et al. (32) 4.9 80 40 
4.7 90 21 
4.5 95 11 
Reichelt et al. (51) 4.7 69 68 
4.5 82 54 
Agarwal et al. (52) in their study concluded that while previously neglected as a 
screening test for GDM, in selected high-risk populations the FPG offers a potentially 
simple, practical algorithm to screen for GDM by being cost-effective and patient 
friendly. 
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5 OBJECTIVESOFSTUDY 
5.1 To evaluate fasting plasma glucose as a screening test for gestational diabetes 
mellitus- its' sensitivity and specificity. 
5.1.1 To assess sensitivity and specificity of fasting plasma glucose level of 
?.7.0 mmoVl in detecting gestational diabetes mellitus as a whole. 
5 .1.2 To assess sensitivity and specificity of fasting plasma glucose level of 
?.7.0 mmoVl in detecting subcategory gestational diabetes mellitus. 
5.1.3 To assess sensitivity and specificity of fasting plasma glucose level 
between ?. 6.1 to < 7. 0 mmoVl or impaired fasting glucose (IFG) in 
detecting subcategory gestational impaired glucose tolerance. 
5 .1. 4 To select the cut point that jointly maximizes sensitivity and sensitivity 
in detecting gestational diabetes mellitus as a whole. 
5.2 To determine demographic distribution of gestational diabetes mellitus. 
5.3 To assess the proportions of gestational diabetes mellitus picked up by selective 
screening using historical risk factors alone. 
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6 METHODOLOGY 
This is a hospital-based, cross-sectional study done in Obstetric and Gynaecology clinic 
in Hospital University Science Malaysia from July 1999 till October 2000. Selection of 
patients was done during booking clinic. 
All patients were included in the study except those who are: 
• diabetics outside pregnancy 
• at more than 28 weeks of gestation during booking 
• not willing to participate in the study 
At enrollment, explanation was given regarding the study and verbal consent was 
obtained. A standardized questionnaire was completed and weight and height of each 
patient was measured. Patient was given an appointment for the oral glucose tolerance 
test (OGTT) between 24th and the 28th weeks of pregnancy. However, there were 
patients who defaulted and some of them presented later than the initial appointment 
given after being reminded. 
A standardized 2-h 75-g anhydrous glucose tolerance test was done after an overnight 
fast of at least 8 hours. GDM is defined according to the Definition, Diagnosis and 
Classification of Diabetes Mellitus and its Complications. Part 1 :Diagnosis and 
Classification of Diabetes Mellitus Provisional Report of a WHO Consultation (53). 
Venous plasma glucose level was measured using glucose oxidase method in the 
hospital laboratory. 
lR 
Glycemic alterations were defined on the basis of the fasting and 2-h post glucose 
levels and pregnant women who meet WHO criteria for diabetes mellitus or IGT are 
classified as having GDM as a whole. 
Table 6.1 Values for diagnosis of subcategories of gestational diabetes mellitus 
Glucose concentration (mmol/1) 
Subcategory Gestational Diabetes 
Mellitus: ~ 7.0 
Fasting 
or ~11.1 
2-h post glucose load 
or both 
. 
Subcategory Gestational Impaired 
Glucose Tolerance (GIGT): <7.0 
Fasting 
and ~ 7. 8 and < 11.1 
2-h post glucose load 
Gestational Diabetes Mellitus as a Both subcategories included 
whole: 
Screening properties of calculated sensitivity, specificity, predictive values (positive 
and negative) and the percentage of women categorized as positive for each value of 
FPG were calculated according to standard procedures. 
Receiver operator characteristic (ROC) curves were plotted to allow the choice of cut 
points that optimize sensitivity and specificity. With this, a comparison of sensitivity 
with the false-positive rate is made for each cut point (27.9,10). The left superior comer 
of the curve represents the cut point that jointly maximizes sensitivity and specificity. 
When this is not clearly evident, the point at which a diagonal line (from maximal 
sensitivity to minimal false-positive rate) intercepts the curve can be used. Secondly, a 
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value that maximizes sensitivity without undue loss of specificity of at least 50% was 
examined. 
Analyses were performed using Bpi-Info version 6.02 and SPSS 9.0 for Windows. 
20 
7 RESULTS 
7.1 General outcome 
This is a hospital-based study conducted from July 1999 till October 2000 during 
antenatal booking clinic. Out of599 patients who were interviewed, 461 agreed to 
participate in the study. However, 91 of them did not turn up for an oral glucose 
tolerance test (OGTT) at the appointed time. From 370 patients who completed the test, 
35 of them delivered at another delivery centre. 
Figure 7.1 Outcome of patients who enrolled for the study 
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91 370 
/~ 
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7.2 Epidemiological background 
7.2.1 Age group 
The patients' age were noted in term of' completed years' then converted into various 
age groups. The mean age ofthe 370 women was 32.34 + 6.01 years of age. 
Figure 7.2 Distribution of patients according to age groups ( c~mpleted years) 
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7.2.2 Ethnic group 
The majority of patients involved in this study were Malay followed by Chinese, others 
(Siamese) and Indian. This correlate well with the distribution of population in the state. 
Figure 7.3 Distribution of patients according to ethnic distribution 
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7.2.3 Prepregnancy weight data 
To calculate body mass index, patients were asked about their prepregnancy weight 
from their memory. Only about more than half of total could recall the data. Among 
those who were not able to give their prepregnancy weight, weight at booking were 
taken which were either in the first trimester (9.2%), the second trimester (32.4%) or 
the third trimester (6.2%). 
Figure 7.4 Prepregnancy weight data 
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7.2.4 Grades of obesity according to body mass indices (BMI) 
BMI that was calculated from the available data ranged from 15.0 to 49.1 kg/m2 with a 
mean of25.15 + 5.1 kg/m2. From 370 patients, 177 (47.8%) ofpatients hadBMI more 
than the desirable weight. 
Figure 7.5 Distribution of patients according to grades of obesity 
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7.2.5 Gravidity 
Majority of patients were multigravidas with 59.2% were gravidae 2 to 5 and 23.5% 
were gravidae 6 to 10. The highest gravidity is 14. Primigravida made upl5.7% of the 
studied population. 
Figure 7.6 Distribution of patients according to gravidity 
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Middle-income group made up 64.3% of the patients in the study group. Almost a third 
of them were in the high-income group. 
Figure 7. 7 Distribution of patients according to income groups 
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